October 10, 2007 (Seattle) — A report from a military emergency unit in Iraq may indicate that a change in the timing of administration of recombinant factor VIIa (rFVIIa) could significantly improve ...
NEW ORLEANS — A new trial of recombinant factor VIIa in patients with intracerebral hemorrhage (ICH) showed neutral overall results but raised the possibility that the therapy could help stop bleeding ...
With a U.S. biotech identified as One Bio, Jiangsu Hengrui Pharmaceutical Co. Ltd. has inked an out-licensing deal potentially worth $1.05 billion for its asthma ...
Factor VII deficiency is a rare, autosomal recessive bleeding disorder marked by reduced levels or dysfunction of coagulation factor VII, a crucial initiator of the extrinsic coagulation cascade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results